𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation

✍ Scribed by Paolo Piacentini; Massimo Donadelli; Chiara Costanzo; Patrick S. Moore; Marta Palmieri; Aldo Scarpa


Publisher
Springer
Year
2006
Tongue
English
Weight
474 KB
Volume
448
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A lipophilic vasoactive intestinal pepti
✍ Edgar Gelber; Ruth Granoth; Mati Fridkin; Zeev Dreznik; Douglas E. Brenneman; Te πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 2 views

## BACKGROUND. Vasoactive intestinal peptide (VIP) is one of several small neuropeptides that affect cancer growth. A lipophilic VIP analog, stearyl-Nle 17 -neurotensin 6-11 VIP 7-28 (SNH) that inhibited lung carcinoma growth has been described previously. The experiments performed were clonogenic

Transforming growth factor-Ξ²1 enhances t
✍ StΓ©phane Raynal; Silvano Nocentini; Alain Croisy; David A. Lawrence; Pierre Jull πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 108 KB πŸ‘ 1 views

In memoriam to the late Philippe Vigier , Emeritus Head of the Department of Retrovirology, Institut Curie. In wartime he fought for the freedom of his country, in peacetime for the elucidation of cancer.

The efficacy of a novel, dual PI3K/mTOR
✍ Niranjan Awasthi; Peter L. Yen; Margaret A. Schwarz; Roderich E. Schwarz πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 419 KB

## Abstract Gemcitabine has limited clinical benefits for pancreatic ductal adenocarcinoma (PDAC). The phosphatidylinositol‐3‐kinase (PI3K)/AKT and mammalian target of rapamycin (mTOR) signaling pathways are frequently dysregulated in PDAC. We investigated the effects of NVP‐BEZ235, a novel dual PI